DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 99 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $153,000 | -33.8% | 10,848 | -79.1% | 0.00% | – |
| Q4 2020 | $231,000 | +23.5% | 51,848 | +19.7% | 0.00% | – |
| Q3 2020 | $187,000 | -64.7% | 43,308 | -27.5% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | +430.0% | 59,708 | +137.2% | 0.00% | – |
| Q2 2019 | $100,000 | -56.9% | 25,177 | -20.8% | 0.00% | – |
| Q1 2019 | $232,000 | -12.1% | 31,803 | +10.1% | 0.00% | – |
| Q4 2018 | $264,000 | -36.5% | 28,882 | -13.9% | 0.00% | -100.0% |
| Q3 2018 | $416,000 | -20.8% | 33,562 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $525,000 | +109.2% | 34,435 | +195.0% | 0.00% | 0.0% |
| Q3 2017 | $251,000 | +512.2% | 11,673 | +11.4% | 0.00% | – |
| Q4 2016 | $41,000 | -63.7% | 10,482 | -3.1% | 0.00% | – |
| Q3 2016 | $113,000 | -81.1% | 10,812 | -55.7% | 0.00% | -100.0% |
| Q3 2015 | $598,000 | +8.9% | 24,380 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $549,000 | -1.4% | 23,437 | -5.6% | 0.00% | 0.0% |
| Q1 2015 | $557,000 | – | 24,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |